Press releases

2017-10-26 – Press release

Topas Therapeutics Appoints Rupert Sandbrink, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer

  • Highly accomplished pharmaceutical executive with many years of clinical development, medical affairs, and regulatory experience at Bayer and Schering
  • To lead Topas’ clinical development and regulatory affairs

read more …

2017-08-22 – Press release

Topas Therapeutics signs multi-year research and option agreement with Lilly focused on immune tolerance

read more …

2017-04-04 – Press release

Paul Sekhri joins Topas Therapeutics as Chairman of the Board

read more …